ABSTRACT
Air pollution is increasingly discussed as a risk factor for dementia, but the biological mechanisms are not yet fully understood. Cellular integrity markers like telomere length are relevant to investigate in relation to air pollution exposure in this context, as they are associated with aging and dementia. Previous studies on air pollution and telomere length have somewhat mixed results, which may partly be due to differences in air pollution modelling, composition, and concentrations. The study aimed to investigate the relationship between source-specific air pollution exposure and telomere length in a low-level air pollution area.
Data were obtained from the Betula project, a longitudinal study in Northern Sweden dedicated to studying aging, memory and dementia. A total of 519 participants who were recruited between 1988 and 1995 were included, whose relative telomere length was measured, and who were followed-up with respect to dementia for more than 20 years. To estimate annual mean air pollution concentrations, a dispersion model linked to each participant’s residential address was employed. We conducted linear regression to explore the associations between annual mean air pollution concentrations at participants’ residences and relative leukocyte telomere length.
In the whole sample, there was no support for air pollution to affect telomere length, with regression slope estimates close to zero and p-values >0.10. There were tendencies for a positive association of longer telomere length and higher exposure to air pollution among individuals who were later diagnosed with dementia (N = 74), but these findings were not conclusive (p-values >0.10). The findings raise questions about susceptibility to air pollution and the state of the inflammatory response in individuals who later will develop dementia. Given the imprecise nature of these estimates, caution is advised in their interpretation however, and validation in other studies is essential.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the ethics review authority in Sweden with Dnr: 2022-04608-01.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Data are available from the Umeå University for researchers who meet the criteria for access to confidential data. https://www.umu.se/en/research/projects/betula---aging-memory-and-dementia/
